Don't Miss

INTERVIEW: Frontier IP Group Plc Stake in Cambridge Material Testing Solutions a positive step forward
INTERVIEW: Live Company Group Extending South Korean Contract
INTERVIEW: Deltex Medical Group New CEO Andy Mears
INTERVIEW: Metal Tiger Copper Confirmed at New A4 Dome Target
INTERVIEW: Savannah Resources Scoping Study Results
INTERVIEW: Evgen Pharma STEM trial positive early signs
INTERVIEW: Widecells Group Placing and Looking ahead
INTERVIEW: Jubilee Metals PlatCro could be bigger than Hernic Project

DirectorsTalk LSE Stock market news, financial, press release, articles and interviews

Home
- Search
Market News
Exclusives
BrokerTalk
- Zeus Capital
Companies
CEO Q & A’s
Research
- Hardman Research
- Zeus Capital
Add Your News
Charts

Home » Hardman Research

Hardman Research

Redx Pharma Plc “Focus, Realism and Results” – Ian Ross, Chairman

21st June 2018

Redx Pharma Plc (LON:REDX) new management team is focusing its financial resources (ca.£10m) on progressing its lead candidates in oncology and fibrotic disease into the clinic. Although the first patient ...
Read Article »
Warpaint London PLC Painting a bright future

18th June 2018
Oxford BioMedica Gene-therapy for Parkinson’s: clinical progression

18th June 2018
Koovs plc Successful fund raising

18th June 2018
Evgen Pharma Encouraging interim data from the STEM trial

13th June 2018
Chamberlin Plc Trading strong, technical issues largely resolved

5th June 2018
Avacta In vivo expression of Affimers

31st May 2018
Gateley (Holdings) Plc Fiscal 2018 Trading Update and Acquisition

31st May 2018
Bionomics Ltd Third Phase II trial of BNC210 begins

30th May 2018
R.E.A. Holdings An Elegant Solution

23rd May 2018
Allergy Therapeutics Plc Opening the door to registration

22nd May 2018
Morses Club FY18: carefully controlled, sustainable growth

16th May 2018
Redx Pharma Clinical and corporate update

16th May 2018
Titon Holdings Plc Justice and favour

15th May 2018
Non-Standard Finance Plc – Everyday Loans: a heart of gold

15th May 2018
Inland Homes plc INL:DNA (interim results)

30th April 2018
Alliance Pharma Entering the US market

23rd April 2018
Chamberlin Plc Trading healthy, technical issues improving

12th April 2018
Diurnal Group – Capital increase to support commercial plans

21st March 2018
Advanced Oncotherapy Confidence greatly boosted

15th March 2018
Koovs plc Poised to clean up – the emerging ASOS of India

1st March 2018
Allergy Therapeutics Growth in a tough market

2nd February 2018
Avacta Group Affimer Drug Conjugates a reality

15th January 2018
Advanced Oncotherapy Consolidating market

21st December 2017
Collagen Solutions Targeting long-term sustainable growth

19th December 2017
Diurnal Group Alkindi®: On route to Europe

19th December 2017
ValiRx Plc Clinical efficacy of VAL401

18th December 2017
genedrive plc Remodelled for growth

13th December 2017
Advanced Oncotherapy Distribution agreement and capital increase

13th December 2017
Evgen Pharma Funded to the end of Phase II trials

11th December 2017
Non-Standard Finance Loan growth, better impairments, more investment

7th December 2017
Hardman Agribusiness: Jatropha Sector Review

6th December 2017
Homes for investors UK residential REITs: the start of a journey

30th November 2017
600 Group Plc Moving into a new growth phase

23rd November 2017
Redx Pharma Streamlined and clean

14th November 2017
Inland Homes plc …….in land we trust

9th November 2017
AIM – A Decade of Achievement Hardman & Co Monthly

7th November 2017
Murgitroyd Group Plc Global growth coming through

25th October 2017
Q&A with Keith Hiscock Chief Executive Officer at Hardman & Co

20th October 2017
Chamberlin Plc One-off cost inefficiencies lead to lower forecasts

18th October 2017
Alliance Pharma Kelo-cote building international sales

17th October 2017

Page 1 of 2412 3 4 5 » 10 20...Last »

Free News Alerts

Hardman Research

Redx Pharma Plc “Focus, Realism and Results” – Ian Ross, Chairman
21st June 2018
Warpaint London PLC Painting a bright future
18th June 2018
Oxford BioMedica Gene-therapy for Parkinson’s: clinical progression
18th June 2018
Koovs plc Successful fund raising
18th June 2018
Evgen Pharma Encouraging interim data from the STEM trial
13th June 2018
Chamberlin Plc Trading strong, technical issues largely resolved
5th June 2018
Avacta In vivo expression of Affimers
31st May 2018
Gateley (Holdings) Plc Fiscal 2018 Trading Update and Acquisition
31st May 2018
Bionomics Ltd Third Phase II trial of BNC210 begins
30th May 2018
R.E.A. Holdings An Elegant Solution
23rd May 2018

UK Broker Ratings

Rio Tinto plc 21.4% Potential Upside Indicated by HSBC

Crest Nicholson Holdings PLC 30% Potential Upside Indicated by Liberum Capital

Capita PLC 15.9% Potential Upside Indicated by Citigroup

Glencore PLC 24.7% Potential Upside Indicated by HSBC

Halma plc 22.5% Potential Decrease Indicated by JP Morgan Cazenove

Electrocomponents plc 27.2% Potential Upside Indicated by Numis

Anglo American plc 14.9% Potential Upside Indicated by HSBC

Berkeley Group Holdings PLC 3.8% Potential Upside Indicated by Deutsche Bank

BHP Billiton plc 13.1% Potential Upside Indicated by HSBC

London Stock Exchange Group Plc 7.9% Potential Upside Indicated by Barclays Capital

B&M European Value Retail SA 22% Potential Upside Indicated by HSBC

BRITISH AMERICAN TOBACCO PLC ADS Common Stock 10.2% Potential Upside Indicated by Liberum Capital

HSS Hire Group PLC 6.3% Potential Decrease Indicated by Numis

J Sainsbury plc 13.6% Potential Decrease Indicated by HSBC

AstraZeneca plc 1.6% Potential Decrease Indicated by Liberum Capital

CEO Interviews

Frontier IP Group Plc

INTERVIEW: Frontier IP Group Plc Stake in Cambridge Material Testing Solutions a positive step forward

Live Company Group PLC

INTERVIEW: Live Company Group Extending South Korean Contract

Deltex Medical Group Plc

INTERVIEW: Deltex Medical Group New CEO Andy Mears

Metal Tiger Plc

INTERVIEW: Metal Tiger Copper Confirmed at New A4 Dome Target

Savannah Resources Plc

INTERVIEW: Savannah Resources Scoping Study Results

Evgen Pharma Plc

INTERVIEW: Evgen Pharma STEM trial positive early signs

WideCells Group PLC

INTERVIEW: Widecells Group Placing and Looking ahead

Jubilee Metals Group

INTERVIEW: Jubilee Metals PlatCro could be bigger than Hernic Project

DirectorsTalk Highlights

Sumo Digital is working on the upcoming Crackdown 3
23rd June 2018
Hydrogen v solid-state battery EVs
23rd June 2018
Singapore to cut the use of cash
23rd June 2018
90-tonne cancer-fighting cyclotron arrives in London
23rd June 2018
Small Businesses That Ignore Lessons from Cyber Attack are Likely to Suffer Another
23rd June 2018
NetDimensions solution for enterprises is recognized as a Leader in the Aragon Research Globe
23rd June 2018
BCA reports stable used car market
22nd June 2018
PSD2: What happens next?
22nd June 2018
World’s Plastic Waste Problem Predicted to Reach 111 Million Metric Tonnes by 2030
22nd June 2018
Be ready for CPD spot checks
22nd June 2018
Webinar: How and why mobile learning is transforming the learning systems market
22nd June 2018
Sativa Investments PLC purchased George Botanicals LTD
22nd June 2018
23,000 Individuals Affected in HealthEquity Breach
22nd June 2018
DRM Residential Joins Leading Portal OnTheMarket
22nd June 2018
Press Officer Mark Guest visits Fulong Resort in China
22nd June 2018
Be bold … A new Gold Standard for smaller companies
22nd June 2018

Trending Articles:

Allergy Therapeutics Plc Opening the door to registration 22nd May 2018
Hydrogen v solid-state battery EVs 23rd June 2018
Singapore to cut the use of cash 23rd June 2018
90-tonne cancer-fighting cyclotron arrives in London 23rd June 2018
NetDimensions solution for enterprises is recognized as a Leader in the… 23rd June 2018
Small Businesses That Ignore Lessons from Cyber Attack are Likely to… 23rd June 2018

Exclusive Interviews

INTERVIEW: Frontier IP Group Plc Stake in Cambridge Material Testing Solutions a positive step forward
20th June 2018
INTERVIEW: Live Company Group Extending South Korean Contract
15th June 2018
INTERVIEW: Deltex Medical Group New CEO Andy Mears
15th June 2018
INTERVIEW: Metal Tiger Copper Confirmed at New A4 Dome Target
15th June 2018
INTERVIEW: Savannah Resources Scoping Study Results
14th June 2018
INTERVIEW: Evgen Pharma STEM trial positive early signs
14th June 2018
INTERVIEW: Widecells Group Placing and Looking ahead
13th June 2018
INTERVIEW: Jubilee Metals PlatCro could be bigger than Hernic Project
12th June 2018

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website. More Info.

Important Links

Privacy Policy | Copyright | Cookies | Contact DirectorsTalk | AIM LSE| AIM | Interviews | RSS News Feed

Add Your News | Become a Sponsor | About Us | Terms & Conditions | Disclaimer & Risk Warning | Subscribe Free | DirectorsTalk TV | Search

© 2018 - DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.